Study finds psilocybin in "magic" mushrooms shows promise as an antidepressant treatment in adults with depression.
A study published by The BMJ suggests that psilocybin, the active ingredient in "magic" mushrooms, shows promise as an antidepressant treatment. The research, which involved a meta-analysis of 436 participants, found that psilocybin treatment had a significant benefit for adults with depression when compared to a control treatment. However, the study also highlighted the need for further research to clarify factors that may moderate psilocybin's effects, such as the type of depression, past use of psychedelics, dosage, and potential publication biases.
May 01, 2024
5 Articles